(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -6.73%144.02B | -4.77%94.32B | -2.46%46.52B | 3.93%197.95B | 8.83%154.41B | 18.37%99.05B | 4.30%47.7B | 8.27%190.46B | 14.53%141.88B | -7.41%83.68B |
Operating income | -6.73%144.02B | -4.77%94.32B | -2.46%46.52B | 3.93%197.95B | 8.83%154.41B | 18.37%99.05B | 4.30%47.7B | 8.27%190.46B | 14.53%141.88B | -7.41%83.68B |
Cost of sales | ---- | 3.63%-75.64B | ---- | -6.58%-157.88B | ---- | -20.52%-78.48B | ---- | -7.13%-148.13B | ---- | 5.69%-65.12B |
Operating expenses | 4.13%-108.34B | 3.63%-75.64B | 1.93%-34.81B | -6.58%-157.88B | -10.54%-113B | -20.52%-78.48B | -7.33%-35.5B | -7.13%-148.13B | -13.50%-102.23B | 5.69%-65.12B |
Gross profit | -13.82%35.68B | -9.14%18.69B | -4.00%11.71B | -5.35%40.07B | 4.44%41.41B | 10.81%20.57B | -3.62%12.2B | 12.46%42.33B | 17.30%39.65B | -12.97%18.56B |
Selling expenses | 5.28%-9.91B | 4.47%-5.41B | 5.81%-2.97B | -5.94%-11.84B | -8.09%-10.46B | -17.79%-5.66B | -7.61%-3.16B | -8.39%-11.18B | -15.51%-9.68B | 11.49%-4.81B |
Administrative expenses | 20.06%-1.35B | -4.79%-2.37B | -23.07%-611.95M | 4.22%-5.11B | 1.99%-1.68B | 0.34%-2.26B | 22.48%-497.23M | 7.95%-5.34B | 34.99%-1.72B | 28.09%-2.27B |
Research and development expenses | -70.37%-1.08B | ---- | 11.18%-165.21M | ---- | -5.42%-634.68M | ---- | -23.83%-186.01M | ---- | 9.55%-602.03M | ---- |
Profit from asset sales | -788.88%-31.35M | ---- | -707.21%-29.67M | ---- | -104.10%-3.53M | ---- | -103.03%-3.68M | ---- | 1,689.68%86.1M | ---- |
Revaluation surplus | 237.01%25.27M | ---- | -93.40%2.73M | ---- | 101.25%7.5M | ---- | 135.97%41.32M | ---- | -87.71%-601.28M | ---- |
-Changes in the fair value of other assets | 237.01%25.27M | ---- | -93.40%2.73M | ---- | 101.25%7.5M | ---- | 135.97%41.32M | ---- | -87.71%-601.28M | ---- |
Impairment and provision | 31.66%-279.56M | 96.14%-11.51M | 2.62%-25.28M | -19.11%-565.22M | 39.64%-409.07M | -245.82%-298.22M | 71.80%-25.96M | -442.41%-474.56M | -33.18%-677.68M | 31.03%-86.23M |
-Other impairment is provision | 31.66%-279.56M | 96.14%-11.51M | 2.62%-25.28M | -19.11%-565.22M | 39.64%-409.07M | -245.82%-298.22M | 71.80%-25.96M | -442.41%-474.56M | -33.18%-677.68M | 31.03%-86.23M |
Special items of operating profit | 70.79%-168.89M | -164.19%-151.29M | -173.05%-108.89M | -97.45%16.92M | -91.55%-578.2M | 286.78%235.67M | -15.46%149.07M | -73.60%663.97M | -171.10%-301.85M | -95.51%60.93M |
Adjustment items of operating profit | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
Operating profit | -22.76%15.61B | -14.58%10.75B | -11.95%5.43B | -13.23%22.57B | 10.33%20.21B | 9.78%12.59B | -3.55%6.17B | 8.55%26.01B | 15.48%18.32B | -17.99%11.46B |
Financing income | ---- | -5.10%200.23M | ---- | -20.28%525.83M | ---- | -43.86%211M | ---- | -25.65%659.63M | ---- | -25.36%375.85M |
Financing cost | 20.38%-388.33M | 22.01%-213.07M | -203.01%-257.46M | 24.81%-495.08M | -178.78%-487.71M | 22.07%-273.19M | -135.68%-84.97M | 20.31%-658.46M | -23.11%619.1M | 14.12%-350.58M |
Special items of earning before tax | 151.03%12.3M | -998.51%-504.31M | 1,750.56%762.87K | -24.91%-1.6B | 67.68%-24.11M | 229.28%56.13M | 89.50%-46.22K | -16.38%-1.28B | -1,269.36%-74.58M | 91.21%-43.41M |
Earning before tax | -22.66%15.24B | -18.65%10.23B | -14.93%5.18B | -15.08%21B | 4.43%19.7B | 9.90%12.58B | -8.29%6.08B | 7.89%24.73B | 13.21%18.86B | -15.71%11.45B |
Tax | 23.48%-4.95B | 16.41%-3.37B | 12.65%-1.68B | 12.15%-7.37B | -1.07%-6.46B | -5.93%-4.03B | 6.87%-1.93B | -8.04%-8.39B | -12.55%-6.4B | 13.50%-3.8B |
After-tax profit from continuing operations | -22.26%10.29B | -19.70%6.87B | -16.00%3.49B | -16.58%13.63B | 6.16%13.24B | 11.88%8.55B | -8.93%4.16B | 7.81%16.34B | 13.55%12.47B | -16.77%7.64B |
Earning after tax | -22.26%10.29B | -19.70%6.87B | -16.00%3.49B | -16.58%13.63B | 6.16%13.24B | 11.88%8.55B | -8.93%4.16B | 7.81%16.34B | 13.55%12.47B | -16.77%7.64B |
Minority profit | -22.02%7.19B | -14.32%4.89B | -9.05%2.46B | -12.71%10.6B | -0.37%9.22B | 4.03%5.71B | -9.88%2.7B | 7.49%12.14B | 11.34%9.25B | -14.63%5.48B |
Shareholders should account for profits from continuing business | ---- | -30.49%1.98B | ---- | ---- | ---- | --2.85B | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -22.79%3.1B | -30.49%1.98B | -28.89%1.03B | -27.79%3.03B | 24.96%4.02B | 31.85%2.85B | -7.12%1.46B | 8.77%4.2B | 20.43%3.22B | -21.75%2.16B |
Basic earnings per share | -30.56%0.25 | -26.92%0.38 | 33.33%0.36 | 8.33%0.52 | -20.59%0.27 | |||||
Diluted earnings per share | -30.56%0.25 | -26.92%0.38 | 33.33%0.36 | 8.33%0.52 | -20.59%0.27 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data